• 2026-01-31
    Innolake Biopharm out-licensed first-in-class ILB-3101 ADC to Ellipses Pharma
    SEE MORE
  • 2025-02-27
    Congratulations！Innolake Biopharm Honored as “Best ADC Developer in China”for 2025 Asia-Pacific Biopharma Excellence Awards
    SEE MORE
<
123
>